DUBLIN–(BUSINESS WIRE)–The “Whooping
Cough – Global Clinical Trial Pipeline Highlights, 2019” report
has been added to ResearchAndMarkets.com’s offering.
This report provides most up-to-date information on key pipeline
products in the global Whooping Cough market. It covers emerging
therapies for Whooping Cough in active clinical development stages
including early and late stage clinical trials.
The pipeline data presented in this report helps executives for tracking
competition, identifying partners, evaluating opportunities, formulating
business development strategies, and executing in-licensing and
out-licensing deals.
Clinical Trial Stages
The report provides Whooping Cough pipeline products by clinical trial
stages including both early and late stage development – phase 3
clinical trials, phase 2 clinical trials, phase 1 clinical trials,
preclinical research, and discovery stage.
Drug Mechanism Classes
The report provides Whooping Cough pipeline products by their dominant
mechanism of action/drug class. This helps executives categorize
products based on their drug class and also assess the strengths and
weaknesses of compounds.
Company
The report provides Whooping Cough pipeline products by the company.
Short-term Launch Highlights
Find out which Whooping Cough pipeline products will be launched in the
US and Ex-US till 2024.
Key Topics Covered
1. Whooping Cough Pipeline by Stages
2. Whooping Cough Phase 3 Clinical Trial Insights
3. Whooping Cough Phase 2 Clinical Trial Insights
4. Whooping Cough Phase 1 Clinical Trial Insights
5. Whooping Cough Preclinical Research Insights
6. Whooping Cough Discovery Stage Insights
7. Appendix
8. Research Methodology
For more information about this report visit https://www.researchandmarkets.com/r/a1ut95
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Clinical
Trials